Anaplastic thyroid carcinoma, <i>BRAF</i> non-V600, <i>NRAS</i>, combination immunotherapy and targeted therapy, case report. The gene discussed is BRAF; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.